<DOC>
	<DOCNO>NCT00001837</DOCNO>
	<brief_summary>This research study design work cooperation another study conduct National Cancer Institute . The National Cancer Institute ( NCI ) study effect drug call raloxifene premenopausal woman believe high risk develop breast cancer ( 98-C-0123 ) . In study , researcher interest learn effect raloxifene uterus ovary woman participate NCI study . To researcher plan conduct ultrasounds patient enrol NCI study . In addition researcher plan take sample line uterus patient ( endometrial biopsy ) find necessary . The purpose study determine reproductive effect raloxifene woman normal functioning ovary take ultrasounds ovary line uterus ( endometrium ) .</brief_summary>
	<brief_title>Effects Raloxifene Uterus Ovaries Premenopausal Patients</brief_title>
	<detailed_description>Raloxifene selective estrogen receptor-modulating agent recently approve FDA treatment osteoporosis postmenopausal patient . A phase II trial evaluate safety efficacy raloxifene premenopausal patient high risk develop breast cancer recently approve IRB ( 98-C-0123 ) . In protocol , assessment effect raloxifene endometrium ovary , patient schedule studied transvaginal sonography hysterosonography , menstrual cycle periodic interval . They also schedule endometrial biopsy indicate . It known SERMs ( clomiphene , tamoxifen one small study raloxifene ) raise area curve estradiol level throughout cycle premenopausal woman . Our study design study reproductive effect raloxifene young woman competent ovary use sonography ovary endometrium , correlate steroid hormone level would obtain protocol 98-C-0123 .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Women must enrol NCI Study 98C0123 .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Sonohysterography</keyword>
	<keyword>Color Doppler Sonography</keyword>
	<keyword>Endometrium</keyword>
	<keyword>Gynecologic</keyword>
	<keyword>Menstrual Cycle</keyword>
	<keyword>Premenopause</keyword>
</DOC>